FdaApplication
NDA 211210
Identifiers
- fda_app_no: NDA211210
Properties
| Property | Value |
|---|---|
| applicant_name | TERSERA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2018-10-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QMIIZ ODT | MELOXICAM | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| QMIIZ ODT | MELOXICAM | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
2 products